Cargando…

Insights in the maturational processes influencing hydrocortisone pharmacokinetics in congenital adrenal hyperplasia patients using a middle-out approach

Introduction: Hydrocortisone is the standard of care in cortisol replacement therapy for congenital adrenal hyperplasia patients. Challenges in mimicking cortisol circadian rhythm and dosing individualization can be overcome by the support of mathematical modelling. Previously, a non-linear mixed-ef...

Descripción completa

Detalles Bibliográficos
Autores principales:	Michelet, Robin, Bindellini, Davide, Melin, Johanna, Neumann, Uta, Blankenstein, Oliver, Huisinga, Wilhelm, Johnson, Trevor N., Whitaker, Martin J., Ross, Richard, Kloft, Charlotte
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877293/ https://www.ncbi.nlm.nih.gov/pubmed/36712688 http://dx.doi.org/10.3389/fphar.2022.1090554

Ejemplares similares

Model-Informed Target Morning 17α-Hydroxyprogesterone Concentrations in Dried Blood Spots for Pediatric Congenital Adrenal Hyperplasia Patients
por: Stachanow, Viktoria, et al.
Publicado: (2023)

Exploring Dried Blood Spot Cortisol Concentrations as an Alternative for Monitoring Pediatric Adrenal Insufficiency Patients: A Model-Based Analysis
por: Stachanow, Viktoria, et al.
Publicado: (2022)

Modified-Release Hydrocortisone in Congenital Adrenal Hyperplasia
por: Merke, Deborah P, et al.
Publicado: (2021)

Alterations in Hydrocortisone Pharmacokinetics in a Patient With Congenital Adrenal Hyperplasia Following Bariatric Surgery
por: Mallappa, Ashwini, et al.
Publicado: (2017)

Nocturnal Dexamethasone versus Hydrocortisone for the Treatment of Children with Congenital Adrenal Hyperplasia
por: Dauber, Andrew, et al.
Publicado: (2010)

Hydrocortisone dosing in children with classic congenital adrenal hyperplasia: results of the German/Austrian registry
por: Hoyer-Kuhn, Heike, et al.
Publicado: (2021)

Impact of food, alcohol and pH on modified-release hydrocortisone developed to treat congenital adrenal hyperplasia
por: Karunasena, Nayananjani, et al.
Publicado: (2017)

Differential effects of hydrocortisone, prednisone, and dexamethasone on hormonal and pharmacokinetic profiles: a pilot study in children with congenital adrenal hyperplasia
por: Nebesio, Todd D., et al.
Publicado: (2016)

Similar Piperacillin/Tazobactam Target Attainment in Obese versus Nonobese Patients despite Differences in Interstitial Tissue Fluid Pharmacokinetics
por: Busse, David, et al.
Publicado: (2021)

A Prospective Study of Children Aged 0–8 Years with CAH and Adrenal Insufficiency Treated with Hydrocortisone Granules
por: Neumann, Uta, et al.
Publicado: (2020)

Results of the Prolonged Use of Subcutaneous Continuous Infusion of Hydrocortisone in a Man with Congenital Adrenal Hyperplasia
por: Sonnet, Emmanuel, et al.
Publicado: (2011)

Would Cortisol Measurements Be a Better Gauge of Hydrocortisone Replacement Therapy? Congenital Adrenal Hyperplasia as an Exemplar
por: Hindmarsh, Peter C, et al.
Publicado: (2020)

OR25-02 A Phase 3 Study of a Modified-Release Hydrocortisone in the Treatment of Congenital Adrenal Hyperplasia
por: Merke, Deborah P, et al.
Publicado: (2020)

Access to fludrocortisone and to hydrocortisone in children with congenital adrenal hyperplasia in the WHO Eastern Mediterranean Region: it takes a village…
por: Rowlands, Amanda, et al.
Publicado: (2021)

A pilot study on the effect of three hydrocortisone dosing regimen on 17 hydroxyprogesterone levels in patients with congenital adrenal hyperplasia
por: Salud, Josephine Leiya Marie F, et al.
Publicado: (2013)

SUN-358 Dual Release Hydrocortisone as a New Treatment for Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
por: Simeoli, Chiara, et al.
Publicado: (2019)

Congenital adrenal hyperplasia
por: Dessinioti, Cleo, et al.
Publicado: (2009)

Congenital Adrenal Hyperplasia
por: Speiser, Phyllis W.
Publicado: (2015)

Nonlinear pharmacokinetics of therapeutic proteins resulting from receptor mediated endocytosis
por: Krippendorff, Ben-Fillippo, et al.
Publicado: (2009)

SAT-009 Proof of Concept That Corticosterone Has a Higher Therapeutic Index Than Hydrocortisone in Patients with Congenital Adrenal Hyperplasia
por: Kyle, Catriona, et al.
Publicado: (2019)

Long-term prednisone versus hydrocortisone treatment in children with classic congenital adrenal hyperplasia (CAH) and a brief review of the literature
por: Ahmed, Shaymaa Elsayed Abdel Meguid, et al.
Publicado: (2019)

RF09 | PSAT70 Comparison of Prednisolone Versus Modified-release Hydrocortisone (Efmody) in the Treatment of Congenital Adrenal Hyperplasia (CAH)
por: Merke, Deborah P, et al.
Publicado: (2022)

Towards Model-Informed Precision Dosing of Voriconazole: Challenging Published Voriconazole Nonlinear Mixed-Effects Models with Real-World Clinical Data
por: Kluwe, Franziska, et al.
Publicado: (2023)

Nonclassic Congenital Adrenal Hyperplasia
por: Witchel, Selma Feldman, et al.
Publicado: (2010)

Congenital lipoid adrenal hyperplasia
por: Kim, Chan Jong
Publicado: (2014)

Comparative Plasma and Interstitial Tissue Fluid Pharmacokinetics of Meropenem Demonstrate the Need for Increasing Dose and Infusion Duration in Obese and Non-obese Patients
por: Busse, David, et al.
Publicado: (2021)

Real-World Estimates of Adrenal Insufficiency–Related Adverse Events in Children With Congenital Adrenal Hyperplasia
por: Ali, Salma R, et al.
Publicado: (2020)

Testicular Adrenal Rest Tumours in Congenital Adrenal Hyperplasia
por: Claahsen-van der Grinten, H. L., et al.
Publicado: (2009)

Adrenal Hypoplasia Congenita Presenting as Congenital Adrenal Hyperplasia
por: Flint, Jennifer L., et al.
Publicado: (2013)

Giant Bilateral Adrenal Myelolipoma with Congenital Adrenal Hyperplasia
por: Al-Bahri, S., et al.
Publicado: (2014)

Landscape of Adrenal Tumours in Patients with Congenital Adrenal Hyperplasia
por: Carsote, Mara, et al.
Publicado: (2023)

Management of the Adult with Congenital Adrenal Hyperplasia
por: Auchus, Richard J.
Publicado: (2010)

Congenital adrenal hyperplasia: Treatment and outcomes
por: Kamoun, Mahdi, et al.
Publicado: (2013)

Nonclassical Congenital Adrenal Hyperplasia and Pregnancy
por: Cuhaci, Neslihan, et al.
Publicado: (2015)

Assisted Reproduction in Congenital Adrenal Hyperplasia
por: Chatziaggelou, Anastasios, et al.
Publicado: (2019)

Novel treatments for congenital adrenal hyperplasia
por: Schröder, Mariska A. M., et al.
Publicado: (2022)

Adrenal crisis and mortality rate in adrenal insufficiency and congenital adrenal hyperplasia
por: Lousada, Lia Mesquita, et al.
Publicado: (2021)

Quantification of the Time Course of CYP3A Inhibition, Activation, and Induction Using a Population Pharmacokinetic Model of Microdosed Midazolam Continuous Infusion
por: Nassar, Yomna M., et al.
Publicado: (2022)

Ulcerative Colitis and Acute Severe Ulcerative Colitis Patients Are Overlooked in Infliximab Population Pharmacokinetic Models: Results from a Comprehensive Review
por: Démaris, Alix, et al.
Publicado: (2022)

Analysis of therapy monitoring in the International Congenital Adrenal Hyperplasia Registry
por: Lawrence, Neil, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ps5j7b1p1m2ip9lfect7lpv332